Kolexia
Morand-Joubert Laurence
Biologie médicale
Hôpital Saint-Antoine
Paris, France
230 Activités
12 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH COVID-19 Infections opportunistes Syndrome d'immunodéficience acquise Virémie Séropositivité VIH Maladie grave Sarcome de Kaposi Fièvre

Industries

Gilead
35 collaboration(s)
Dernière en 2023
Edimark
28 collaboration(s)
Dernière en 2023
ViiV Healthcare
26 collaboration(s)
Dernière en 2023
MSD
22 collaboration(s)
Dernière en 2023

Dernières activités

Dolutegravir/rilpivirine (DTG/RPV) therapy as a maintenance treatment in PLWH with past virological failures and resistance-associated mutations to NNRTIs and INSTIs
HIV medicine Congress 2023   01 décembre 2023
ANRS 177 DUETTO randomized, open-label and multicentric trial evaluating the non-inferiority of maintenance antiretroviral dual therapy taken 4 consecutive days per week versus dual therapy 7/7 days per week
HIV medicine Congress 2023   01 décembre 2023
Efficacy and Tolerance of the BNT162b2 Vaccine in Children with Acute Leukemia and Their Siblings: Results of the Phase I-II Pacific Trial
65th ASH Annual Meeting Abstracts   02 novembre 2023
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variants BA.2, BA.5 and BQ.1.1 in critically ill patients with COVID-19: a prospective, multicenter cohort study.
Intensive care medicine experimental   07 août 2023
Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance.
The Journal of antimicrobial chemotherapy   02 juin 2023
Hepatitis B Virus in West African Children: Systematic Review and Meta-Analysis of HIV and Other Factors Associated with Hepatitis B Infection.
International journal of environmental research and public health   25 février 2023
Prevalence of HIV-1 Natural Polymorphisms and Integrase-Resistance-Associated Mutations in African Children.
Viruses   16 février 2023
SARS-CoV-2 Neutralizing Responses in Various Populations, at the Time of SARS-CoV-2 Variant Virus Emergence: Evaluation of Two Surrogate Neutralization Assays in Front of Whole Virus Neutralization Test.
Life (Basel, Switzerland)   09 décembre 2022
Author Correction: Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19.
Nature communications   07 décembre 2022
COVID-19 acute respiratory distress syndrome promotes a specific alternative macrophage polarization.
Immunology letters   13 novembre 2022